Your browser version may not work well with NCBI's Web applications. More information here...
1: Bioorg Med Chem. 2007 Jan 1;15(1):283-7. Epub 2006 Sep 29.Click here to read Click here to read Links

The triphosphate of beta-D-4'-C-ethynyl-2',3'-dideoxycytidine is the preferred enantiomer substrate for HIV reverse transcriptase.

Laboratory of Medicinal Chemistry, Center for Cancer Research, NCI-Frederick, NIH, Frederick, MD 21702, USA.

The enantioselective synthesis of the beta-d (1) enantiomer of 4'-C-ethynyl-2',3'-dideoxycytidine confirms an earlier stereochemical assignment that was strictly based on the ability of HIV reverse transcriptase and its M184V mutant to discriminate between the d- and l-configuration of nucleoside 5'-triphosphates.

PMID: 17046266 [PubMed - indexed for MEDLINE]

PMCID: PMC1764207